Govt likely to enlist pharma companies for medicine bank
SOCIAL CAUSE Bank to be used during public health crises
NEW DELHI: Drug makers may have to contribute medicines equivalent of at least 1% of their average profit in the past three years to create a medicine bank that will be used during public health emergencies in India or abroad, according to a government proposal.
The contributions, which will be considered part of the firms’ mandatory corporate social responsibility (CSR) activity, will be used to provide free medicines during a public health crisis in India or in a foreign nation, the health ministry’s proposal said.
While the contributions will be voluntary initially, the government is considering changes to the Drugs and Cosmetics Rules, 1945, to make it mandatory at a later stage.
“The Drug Technical Advisory Board (at its May 16 meeting) decided that it should be left to companies to contribute on a voluntary basis but later, it will be made part of the rules, making it mandatory for the companies to share a part of their profit for a noble cause,” said S Eswara Reddy, Drug Controller General of India.
The latest proposal is among several measures through which the government has co-opted the private sector to deliver health
The government is planning to ask pharmaceutical companies to contribute to a medicine bank as part of their CSR activity
The medicine bank will be used to provide free medicines during a public health crisis in India or in a foreign country care to its citizens. This time, the government has taken a step further in proposing to provide drugs in other countries also which are facing public health crises such as epidemics.
The Union health ministry will soon take up the matter with the law ministry to make necessary changes to the drugs and cosmetics rules.
“As long as it is out of the CSR provision, the industry would contribute happily as they would be saving lives of people,” said DG Shah, secretary general of the Indian Pharmaceutical Alli- ance, which represents 20 of the country’s biggest drug makers.
CSR rules mandate companies with a net worth of more than ₹500 crore or revenue above ₹1,000 crore or net profit higher than ₹5 crore to spend 2% of their average profit in the last three years on social development-related activities.
The so-called medicine bank, according to three health ministry officials aware of the matter, can be used in case of epidemics in other countries as well and will help improve India’s relationship with these nations.